The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases

Clinical and Experimental Immunology

Volumn 178, Issue 2, 2014, Pages 262-269

  Inoue, N ^a   Watanabe, M ^a   Ishido, N ^a   Katsumata, Y ^a   Kagawa, T ^a   Hidaka, Y ^a   Iwatani, Y ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune thyroid disease; Intractability; Polymorphism; Severity; Vitamin D

Indexed keywords

CALCITRIOL RECEPTOR; CHOLESTANETRIOL 26 MONOOXYGENASE; CYP2R1 PROTEIN, HUMAN; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ALLELE; CASE CONTROL STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MALE; MIDDLE AGED; THYROIDITIS, AUTOIMMUNE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHOLESTANETRIOL 26-MONOOXYGENASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; THYROIDITIS, AUTOIMMUNE; VITAMIN D-BINDING PROTEIN; YOUNG ADULT;

EID: 84908192317     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12420     Document Type: Article

References (37)

1. Weetman AP. Chronic autoimmune thyroiditis. In: Braverman L, Utiger R, eds. The thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams & Wilkins, 2000:721-732.
2. Menconi F, Oppenheim YL, Tomer Y. Graves' disease. In: Shoenfeld Y, Cervera R, Gershwin ME, eds. Diagnostic criteria in autoimmune diseases. Totowa, NJ: Humana Press, 2008:231-235.
3. Nanba T, Watanabe M, Akamizu T, Iwatani Y. The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin Chem 2008; 54:621-623.
4. Ito C, Watanabe M, Okuda N, Watanabe C, Iwatani Y. Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-gamma gene. Endocr J 2006; 53:473-478.
5. Hayashi F, Watanabe M, Nanba T, Inoue N, Akamizu T, Iwatani Y. Association of the -31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells. Clin Exp Immunol 2009; 158:281-286.
6. Inoue N, Watanabe M, Morita M etal. Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. Clin Exp Immunol 2011; 163:318-323.
7. Inoue N, Watanabe M, Morita M etal. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Exp Immunol 2010; 162:402-406.
8. Inoue N, Watanabe M, Nanba T, Wada M, Akamizu T, Iwatani Y. Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotrophin receptor antibody. Clin Exp Immunol 2009; 156:199-204.
9. Tomizawa R, Watanabe M, Inoue N etal. Association of functional GITR gene polymorphisms related to expression of glucocorticoid-induced tumour necrosis factor-receptor (GITR) molecules with prognosis of autoimmune thyroid disease. Clin Exp Immunol 2011; 165:141-147.
10. Inoue N, Watanabe M, Yamada H etal. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3 and ZFAT, previously revealed in genome-wide association studies. J Clin Immunol 2012; 32:1243-1252.
11. Morita M, Watanabe M, Inoue N etal. Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease. Autoimmunity 2011; 45:129-136.
12. Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. 1Alpha, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009; 45:190-197.
13. Peelen E, Knippenberg S, Muris AH etal. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 2011; 10:733-743.
14. Smolders J, Peelen E, Thewissen M etal. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009; 8:621-626.
15. El Gawad SS, Samee ER, Metwali AA, El Gawad MS. Vitamin D receptor gene polymorphism and its association with 1, 25-dihydroxyvitamin D3 in patients with graves disease in Egyptian population: a pilot study. Endocr Pract 2011; 18:132-139.
16. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009; 132:1146-1160.
17. Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid 2011; 21:891-896.
18. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine 2010; 77:552-557.
19. Li K, Shi Q, Yang L etal. The association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with generalized vitiligo. Br J Dermatol 2012; 167:815-821.
20. Shimada A, Kanazawa Y, Motohashi Y etal. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 2008; 30:207-211.
21. Agliardi C, Guerini FR, Saresella M etal. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav Immun 2011; 25:1460-1467.
22. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 2000; 85:4639-4643.
23. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid 2001; 11:607-608.
24. Chen RH, Chang CT, Chen HY, Chen WC, Tsai CH, Tsai FJ. Association between vitamin-D receptor gene FokI polymorphism and Graves' disease among Taiwanese Chinese. J Clin Lab Anal 2007; 21:173-177.
25. Ahn J, Yu K, Stolzenberg-Solomon R etal. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010; 19:2739-2745.
26. Wang TJ, Zhang F, Richards JB etal. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376:180-188.
27. Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 1993; 92:183-188.
28. Abbas S, Linseisen J, Slanger T etal. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev 2008; 17:1339-1343.
29. Lauridsen AL, Vestergaard P, Hermann AP etal. Plasma concentrations of 25-hydroxy-vitamin D and 1, 25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin d-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 2005; 77:15-22.
30. Bu FX, Armas L, Lappe J etal. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet 2010; 128:549-556.
31. Ramos-Lopez E, Bruck P, Jansen T, Herwig J, Badenhoop K. CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes Metab Res Rev 2007; 23:631-636.
32. van Etten E, Verlinden L, Giulietti A etal. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol 2007; 37:395-405.
33. Watanabe M, Yamamoto N, Maruoka H etal. Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid 2002; 12:801-808.
34. Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 2009; 19:495-501.
35. Kivity S, Agmon-Levin N, Zisappl M etal. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 2011; 8:243-247.
36. Zhang H, Shih DQ, Zhang X. Mechanisms underlying effects of 1, 25-dihydroxyvitamin D3 on the Th17 cells. Eur J Microbiol Immunol (Bp) 2013; 3:237-240.
37. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009; 27:485-517.